Nevro Debt to Equity Ratio 2013-2019 | NVRO
Current and historical debt to equity ratio values for Nevro (NVRO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Nevro debt/equity for the three months ending December 31, 2019 was 0.84.
| Nevro Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-12-31 | $0.18B | $0.22B | 0.84 |
| 2019-09-30 | $0.18B | $0.20B | 0.91 |
| 2019-06-30 | $0.18B | $0.20B | 0.89 |
| 2019-03-31 | $0.18B | $0.21B | 0.83 |
| 2018-12-31 | $0.15B | $0.25B | 0.62 |
| 2018-09-30 | $0.15B | $0.24B | 0.62 |
| 2018-06-30 | $0.15B | $0.25B | 0.61 |
| 2018-03-31 | $0.15B | $0.24B | 0.61 |
| 2017-12-31 | $0.15B | $0.25B | 0.58 |
| 2017-09-30 | $0.14B | $0.24B | 0.59 |
| 2017-06-30 | $0.14B | $0.24B | 0.59 |
| 2017-03-31 | $0.14B | $0.24B | 0.58 |
| 2016-12-31 | $0.14B | $0.25B | 0.56 |
| 2016-09-30 | $0.14B | $0.25B | 0.55 |
| 2016-06-30 | $0.14B | $0.25B | 0.55 |
| 2016-03-31 | $0.02B | $0.23B | 0.09 |
| 2015-12-31 | $0.02B | $0.24B | 0.08 |
| 2015-09-30 | $0.02B | $0.24B | 0.08 |
| 2015-06-30 | $0.02B | $0.26B | 0.08 |
| 2015-03-31 | $0.02B | $0.16B | 0.12 |
| 2014-12-31 | $0.02B | $0.17B | 0.11 |
| 2014-09-30 | $0.00B | $-0.11B | 0.00 |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
| 2013-12-31 | $0.00B | 0.00 | |
| 2013-09-30 | $0.00B | 0.00 | |
| 2012-12-31 | $0.00B | $-0.06B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $3.032B | $0.390B |
| Nevro Corp. is a medical device company. It engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. Nevro has developed and commercialized the Senza (R) spinal cord stimulation (SCS) system for the treatment of chronic pain. Senza, HF10, Nevro and the Nevro logo are trademarks of the company. Nevro Corp. is headquartered in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $114.683B | 23.30 |
| Intuitive Surgical (ISRG) | United States | $54.606B | 40.49 |
| Edwards Lifesciences (EW) | United States | $38.658B | 33.19 |
| DexCom (DXCM) | United States | $24.399B | 145.56 |
| ALCON INC (ALC) | Switzerland | $24.181B | 0.00 |
| IDEXX Laboratories (IDXX) | United States | $20.456B | 49.12 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $19.290B | 12.78 |
| Olympus (OCPNY) | Japan | $18.792B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.701B | 41.44 |
| Teleflex (TFX) | United States | $13.693B | 26.48 |
| STERIS (STE) | Ireland | $11.836B | 25.24 |
| SONOVA HOLDING (SONVY) | Switzerland | $10.810B | 0.00 |
| Masimo (MASI) | United States | $9.804B | 57.09 |
| Hologic (HOLX) | United States | $8.968B | 13.79 |
| Varian Medical Systems (VAR) | United States | $8.851B | 20.59 |
| SARTORIUS AG (SARTF) | Germany | $7.545B | 67.04 |
| ABIOMED (ABMD) | United States | $6.457B | 34.03 |
| Penumbra (PEN) | United States | $5.673B | 166.84 |
| Globus Medical (GMED) | United States | $4.040B | 23.95 |
| Tandem Diabetes Care (TNDM) | United States | $3.839B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $3.576B | 15.46 |
| Wright Medical Group (WMGI) | Netherlands | $3.554B | 394.43 |
| Nihon Kohden (NHNKY) | Japan | $3.192B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $3.049B | 23.47 |
| LivaNova (LIVN) | United Kingdom | $2.041B | 14.89 |
| Integer Holdings (ITGR) | United States | $1.767B | 11.51 |
| Cantel Medical (CMD) | United States | $1.423B | 13.70 |
| Glaukos (GKOS) | United States | $1.314B | 0.00 |
| Luminex (LMNX) | United States | $1.271B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.176B | 23.01 |
| Inogen (INGN) | United States | $1.114B | 47.24 |
| Veracyte (VCYT) | United States | $1.042B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.957B | 50.12 |
| Silk Road Medical (SILK) | United States | $0.931B | 0.00 |
| ShockWave Medical (SWAV) | United States | $0.923B | 0.00 |
| OPKO Health (OPK) | United States | $0.770B | 0.00 |
| Natus Medical (NTUS) | United States | $0.749B | 17.58 |
| Tactile Systems Technology (TCMD) | United States | $0.724B | 67.25 |
| CryoLife (CRY) | United States | $0.644B | 53.13 |
| OrthoPediatrics (KIDS) | United States | $0.623B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.511B | 18.14 |
| Pacific Biosciences Of California (PACB) | United States | $0.443B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.415B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.370B | 16.95 |
| ViewRay (VRAY) | United States | $0.349B | 0.00 |
| AxoGen (AXGN) | United States | $0.329B | 0.00 |
| Intersect ENT (XENT) | United States | $0.317B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.312B | 0.00 |
| Si-Bone (SIBN) | United States | $0.311B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.261B | 0.00 |
| TransMedics (TMDX) | United States | $0.258B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.254B | 0.00 |
| IRadimed (IRMD) | United States | $0.233B | 26.46 |
| Semler Scientific (SMLR) | United States | $0.232B | 27.73 |
| SeaSpine Holdings (SPNE) | United States | $0.208B | 0.00 |
| Stereotaxis (STXS) | United States | $0.205B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.203B | 0.00 |
| Accuray (ARAY) | United States | $0.155B | 0.00 |
| Fluidigm (FLDM) | United States | $0.146B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.114B | 31.00 |
| Restoration Robotics (VERO) | Canada | $0.114B | 0.00 |
| Sientra (SIEN) | United States | $0.098B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.097B | 27.00 |
| Electromed (ELMD) | United States | $0.090B | 24.63 |
| Vermillion (VRML) | United States | $0.076B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.074B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.073B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.061B | 16.23 |
| MRI Interventions (CLPT) | United States | $0.051B | 0.00 |
| ConforMIS (CFMS) | United States | $0.043B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.040B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.040B | 0.00 |
| Neuronetics (STIM) | United States | $0.029B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.025B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.024B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.018B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.018B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.017B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| TransEnterix (TRXC) | United States | $0.015B | 0.00 |
| Neovasc (NVCN) | Canada | $0.015B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.015B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.011B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.011B | 0.00 |
| Dynatronics (DYNT) | United States | $0.010B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.009B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.008B | 12.09 |
| Xtant Medical Holdings (XTNT) | United States | $0.008B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.008B | 0.00 |
| Avinger (AVGR) | United States | $0.008B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.006B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.005B | 0.00 |
| Micron Solutions (MICR) | United States | $0.004B | 0.00 |
| InspireMD (NSPR) | Israel | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
